Graham Cooksley

6.0k total citations · 3 hit papers
42 papers, 4.7k citations indexed

About

Graham Cooksley is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Graham Cooksley has authored 42 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Epidemiology, 29 papers in Hepatology and 5 papers in Infectious Diseases. Recurrent topics in Graham Cooksley's work include Hepatitis B Virus Studies (26 papers), Hepatitis C virus research (25 papers) and Liver Disease Diagnosis and Treatment (11 papers). Graham Cooksley is often cited by papers focused on Hepatitis B Virus Studies (26 papers), Hepatitis C virus research (25 papers) and Liver Disease Diagnosis and Treatment (11 papers). Graham Cooksley collaborates with scholars based in Australia, United States and United Kingdom. Graham Cooksley's co-authors include June W. Halliday, J. Searle, L. W. Powell, Reginald G. Hanson, Elizabeth E. Powell, Teerha Piratvisuth, George Lau, Patrick Marcellin, Seung Woon Paik and Michael Fried and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Gastroenterology.

In The Last Decade

Graham Cooksley

40 papers receiving 4.5k citations

Hit Papers

3 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Natural History of Nonalcoholic Steatohepatitis: A Follow–Up Study of Forty–Two Patients for Up to 21 Years

1990 1.2k citations Elizabeth E. Powell, Graham Cooksley et al. Hepatology profile →
Peginterferon Alfa-2a, Lamivudine, and the Combination for HBeAg-Positive Chronic Hepatitis B

2005 1.1k citations George Lau, Teerha Piratvisuth et al. profile →
Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update

2012 834 citations Yun‐Fan Liaw, Jia‐Horng Kao et al. Hepatology International profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Graham Cooksley Australia	25	4.1k	3.4k	522	380	299	42	4.7k
Chung‐Feng Huang Taiwan	28	2.3k 0.6×	2.3k 0.7×	223 0.4×	171 0.5×	141 0.5×	204	3.2k
Douglas R. LaBrecque United States	33	1.7k 0.4×	1.7k 0.5×	210 0.4×	218 0.6×	394 1.3×	84	3.3k
Guy Neff United States	35	3.0k 0.7×	2.7k 0.8×	687 1.3×	340 0.9×	212 0.7×	141	4.9k
Yoav Lurie Israel	25	1.5k 0.4×	1.3k 0.4×	241 0.5×	220 0.6×	100 0.3×	84	2.4k
Yueyong Zhu China	26	1.4k 0.3×	749 0.2×	330 0.6×	299 0.8×	269 0.9×	111	2.3k
William Alazawi United Kingdom	23	1.6k 0.4×	766 0.2×	379 0.7×	160 0.4×	253 0.8×	67	2.5k
Johannes Wiegand Germany	29	1.9k 0.5×	1.8k 0.5×	149 0.3×	271 0.7×	80 0.3×	132	2.6k
Gian Paolo Caviglia Italy	28	1.5k 0.4×	967 0.3×	214 0.4×	144 0.4×	130 0.4×	171	2.7k
Mark Wright United Kingdom	26	1.2k 0.3×	1.1k 0.3×	109 0.2×	114 0.3×	264 0.9×	81	2.1k
Rosmawati Mohamed Malaysia	21	1.7k 0.4×	1.4k 0.4×	279 0.5×	116 0.3×	72 0.2×	63	2.0k

Countries citing papers authored by Graham Cooksley

Since Specialization

Citations

This map shows the geographic impact of Graham Cooksley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Graham Cooksley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Graham Cooksley more than expected).

Fields of papers citing papers by Graham Cooksley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Graham Cooksley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Graham Cooksley. The network helps show where Graham Cooksley may publish in the future.

Co-authorship network of co-authors of Graham Cooksley

This figure shows the co-authorship network connecting the top 25 collaborators of Graham Cooksley. A scholar is included among the top collaborators of Graham Cooksley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Graham Cooksley. Graham Cooksley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Littlejohn, Margaret, Ros Edwards, Kathy Merlock Jackson, et al.. (2023). Molecular epidemiology of hepatitis B among Indigenous Australians in Queensland and the Torres Strait Islands. Internal Medicine Journal. 54(1). 129–138.

Young, Ross McD., Bruce R. Lawford, Rebecca Mellor, et al.. (2021). Investigation of C-reactive protein and AIM2 methylation as a marker for PTSD in Australian Vietnam veterans. Gene. 803. 145898–145898. 11 indexed citations

Mehta, Divya, Elise Pelzer, Dagmar Bruenig, et al.. (2019). DNA methylation from germline cells in veterans with PTSD. Journal of Psychiatric Research. 116. 42–50. 18 indexed citations

Liaw, Yun‐Fan, Jia‐Horng Kao, Teerha Piratvisuth, et al.. (2012). Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update. Hepatology International. 6(3). 531–561. 834 indexed citations breakdown →

Roberts, Stuart K., Graham Cooksley, Gregory J. Dore, et al.. (2008). Robust antiviral activity of R1626, a novel nucleoside analog. Hepatology. 48(2). 398–406. 87 indexed citations

Vandepapelière, Pierre, George Lau, Geert Leroux‐Roels, et al.. (2007). Therapeutic vaccination of chronic hepatitis B patients with virus suppression by antiviral therapy: A randomized, controlled study of co-administration of HBsAg/AS02 candidate vaccine and lamivudine. Vaccine. 25(51). 8585–8597. 150 indexed citations

Berg, Carl L., Fernando Lopes Gonçales, David Bernstein, et al.. (2006). Re‐treatment of chronic hepatitis C patients after relapse: efficacy of peginterferon‐alpha‐2a (40 kDa) and ribavirin. Journal of Viral Hepatitis. 13(7). 435–440. 27 indexed citations

Roberts, S., Graham Cooksley, David Shaw, et al.. (2006). 731 Interim results of a multiple ascending dose study of R1626, a novel nucleoside analog targeting hcv polymerase in chronic HCV patients. Journal of Hepatology. 44. S269–S269. 36 indexed citations

Sullivan, Sean D., Donald M. Jensen, David Bernstein, et al.. (2004). Cost-Effectiveness of Combination Peginterferon alpha-2a and Ribavirin Compared With Interferon alpha-2b and Ribavirin in Patients With Chronic Hepatitis C. The American Journal of Gastroenterology. 99(8). 1490–1496. 47 indexed citations

10.

Cooksley, Graham. (2004). The importance and benefits of hepatitis A prevention in chronic liver disease patients. Journal of Gastroenterology and Hepatology. 19(S1). S17–20. 7 indexed citations

11.

Hassanein, Tarek, Graham Cooksley, Mark Sulkowski, et al.. (2004). The impact of peginterferon alfa-2a plus ribavirin combination therapy on health-related quality of life in chronic hepatitis C. Journal of Hepatology. 40(4). 675–681. 89 indexed citations

12.

Damme, Pierre Van, J E Banatvala, Sten Iwarson, et al.. (2003). Hepatitis A booster vaccination: is there a need?. The Lancet. 362(9389). 1065–1071. 161 indexed citations

13.

Cooksley, Graham. (2003). The treatment of hepatitis B e antigen-positive chronic hepatitis B with pegylated interferon. Journal of Hepatology. 39. 143–145. 5 indexed citations

14.

Ladhams, Andrew, Christopher Schmidt, Garwin Sing, et al.. (2002). Treatment of non‐resectable hepatocellular carcinoma with autologous tumor‐pulsed dendritic cells. Journal of Gastroenterology and Hepatology. 17(8). 889–896. 57 indexed citations

15.

Sing, Garwin, Di Li, Xiaohua Chen, et al.. (2001). A Molecular Comparison of T Lymphocyte Populations Infiltrating the Liver and Circulating in the Blood of Patients With Chronic Hepatitis B: Evidence for Antigen–Driven Selection of A Public Complementarity–Determining Region 3 (Cdr3) Motif. Hepatology. 33(5). 1288–1298. 25 indexed citations

16.

Chen, Xiaohua, Graham Cooksley, & Garwin Sing. (1998). Distinct Patterns of T Cell Receptor Distribution of Peripheral Blood CD8+ Cells During Different Stages of Chronic Infection with Hepatitis B Virus. Human Immunology. 59(4). 199–211. 12 indexed citations

17.

Sing, Garwin, et al.. (1998). Composition of peripheral blood lymphocyte populations during different stages of chronic infection with hepatitis B virus. Journal of Viral Hepatitis. 5(2). 83–93. 19 indexed citations

18.

Busfield, Frances, et al.. (1997). Association of the HFE C282Y mutation with porphyria cutanea tarda in Australian patients The 47th Annual Meeting of the American Society of Human Genetics was held in Baltimore, Maryland, October 28 to November 1, l997. The American Journal of Human Genetics. 61. 1 indexed citations

19.

Sing, Garwin, et al.. (1993). Hepatitis B virus differentially suppresses myelopoiesis and displays tropism for immature hematopoietic cells. Journal of Virology. 67(6). 3454–3460. 18 indexed citations

20.

Powell, Elizabeth E., Graham Cooksley, Reginald G. Hanson, et al.. (1990). The Natural History of Nonalcoholic Steatohepatitis: A Follow–Up Study of Forty–Two Patients for Up to 21 Years. Hepatology. 11(1). 74–80. 1175 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact